In addition, another pan-deacetylase inhibitor panobinostat showed effectiveness in inducing Hodgkin’s lymphoma cell death [49], while a pan-mTOR inhibitor aided in rhabdomyosarcoma cell apoptosis [50]. Here, MTOR is linked to Hodgkins lymphoma.